Colorectal Cancer Conference 2017

Preliminary Program

Thursday 17 August, 2017
0800 - 0830 Registration
0830 - 1000 Rectal Cancer I - Watch and Wait
Session Chair: A/Prof Peter Gibbs

Can imaging predict complete pathological response?
Dr Teng Han Tan
What is the evidence for Watch and Wait?
Dr Philip Tran
Watch and Wait - a surgical perspective 
Dr Adele Burgess
Chemotherapy after complete response
Dr Rachel Wong
1000 - 1030 Morning Tea
1030 - 1200 Immunotherapy for Colorectal Cancer
Session Chair: Prof Rob Ramsey

Immunotherapy in colorectal cancer
Dr Jayesh Desai
Is there a role for checkpoint inhibitors in neoadjuvant therapy?
Dr Nicole Haynes
Can cancer vaccines enhance chemotherapy and immunotherapy?
Dr Sara Roth           
1200 - 1230 The Jack Mackay Plenary Lecture
Session Chair: Prof Sandy Heriot
Microbes, Microbiota and Colon Cancer
Prof Frank Frizelle
1230 - 1330 Lunch
1330 - 1500 Expanding Perioperative Care for Optimal Outcome
Session Chair: Prof Ian Hayes
Surgical School - adding value to clinical pathways through patient buy-in (ERAS- plus)
Dr Hilmy Ismail
The Prehabilitation Clinic - Improving cancer outcomes by reducing modifiable risk
Prof Bernhard Riedel
Stress and cancer outcomes - Implications for the perioperative team
Dr Jonathan Hiller
1500 - 1530 Afternoon Tea
1530 - 1700 Rectal Cancer II
Session Chair: Mr Satish Warrier
Panel: How should you take out a rectal cancer?
T3NI Close to resection margin male 8cm
Prof Frank Frizelle
Dr Jacob McCormack
A/Prof Craig Lynch
Dr Steve Bell
1700 - 1830 Welcome Drinks Reception

Friday 18 August, 2017
0800 - 0830 Registration
0830 - 1000 Survivorship - are we focusing on the right outcome
PROMS - do they matter?
A/Prof Paul McMurrick
Survivorship - hype or reality?
Ms Nicole Kinnane
Chronic bowel dysfunctions after 'cure'
Ms Carolyn Atkin            
1000 - 1030 Morning Tea
1030 - 1200 Tumour Heterogeneity in Colorectal Cancer
Session Chair: Prof Frederic Hollande

Molecular subtypes of colorectal cancer
Prof John Mariadason            
Proteome heterogeneity in colorectal cancer cell lines and primary tumors
A/Prof Oliver Sieber            
Tumour heterogeneity - does it clinically matter?             
Prof Eva Segelov
1200 - 1230 Plenary
Session Chair: A/Prof Damien Stella
The evolving role of radiology
Dr Kirsten Gormly
1230 - 1330 Lunch
1330 - 1500 Integrated Management of Advanced Polyps and Early Colorectal Cancer
Polyp syndromes
Prof Alex Boussioutas
Imaging of early colorectal tumours  
Dr Kirsten Gormly          
Early rectal cancers - minimal vs maximal
Mr Satish Warrier
Is there a role for radiotherapy in local excision of rectal cancer
Dr Michael Ng            
1500 - 1530 Afternoon Tea
1530 - 1700 Peritoneal Colorectal Cancer
Session Chair: A/Prof Craig Lynch

Chemotherapy for peritoneal disease
A/Prof Michael Michael            
Cytoreductive surgery and HIPEC             
Dr Nabila Ansari
Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) - a new option             
Prof Marc Reymond
1700 - 1715 Conference Close
*please note program is subject to change

Scientific Committee

Professor AG Heriot MA MD MBA FRCS FRCSEd FRACS, Convenor
Consultant Colorectal Surgeon, Peter MacCallum Cancer Centre 

Assoc Professor Peter Gibbs 
Medical Oncologist, Royal Melbourne Hospital

Assoc Professor Ian Hayes
Colorectal Surgeon, Royal Melbourne Hospital

Assoc Professor Sam Ngan
Head of the GI Unit of the Department of Radiation Oncology, Peter MacCallum Cancer Centre

Assoc Professor Craig Lynch
Colorectal Surgeon, Peter MacCallum Cancer Centre

Professor Rob Ramsay
Group Leader of the Differentiation and Transcription Laboratory, Peter MacCallum Cancer Centre

Ms Carolyn Atkin
Stomal Therapy Clinical Nurse Consultant, Peter MacCallum Cancer Centre